Sun Whistleblower Complaint to SEBl – 2: Huge Transactions between Aditya Medisales and Private Companies of Sun’s Promoters
In just over three years, between 2014 and 2017, Aditya Medisales Limited (AML) has had over Rs5,800 crore of transactions with Suraksha Realty, controlled by Sun Pharma’s co-promoter, Sudhir Valia, alleges the new 172-page complaint (with documents) sent by the whistleblower on Sun Pharma to the market regulator, Securities and Exchange Board of India (SEBI). 
Premium Content
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article Gift An Article
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Yearly Digital Access Monthly Digital Access
Already a subscriber ? Log in
Free Helpline
Legal Credit